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Abstract
Background: In eating disorders (EDs) treatment, outcome measurement has traditionally focused on symptom
reduction rather than functioning or quality of life (QoL). Generic QoL measures lack sensitivity for some diagnoses and
many not be responsive in eating disorder patients. This article describes the development and validation of a condition-
specific QoL measure for adolescents and adults with eating disorders – the Eating Disorders Quality of Life Scale
(EDQLS).
Methods: Multi-source and multi-stage methods were used to develop the EDQLS, with participation of patients with
EDs, their family members and ED treatment providers. Sources for domain and item development included 39 articles,
12 patient and 10 treatment provider interviews, and 31 first person narratives from the internet. Four stages of
validation and pre-testing involving 17 patients, 10 family members and 18 providers reduced 233 items to 40 items in
12 domains. These items were pilot tested in 41 ED patients.
Results: The final instrument was then validated in a 12 site sample of 171 individuals aged 14–60 with EDs. All items
showed good dispersion. The total raw mean score was 110 out of 200 (SD 27.6) with higher scores indicating better
QoL. Internal consistency was excellent (Cronbach's alpha = .96) and subscale internal consistency ranged from alpha
.36 to .79 providing evidence for a strong overall construct and some multi-dimensionality. Validity was supported by
significant differences in mean EDQLS according to severity levels on the EDI-2 (F = 95.3, p <.001) and the BSI (F = 86.9,
p <.001). EDQLS scores were positively associated with time in treatment (F = 4.65, p = .01) suggesting responsiveness.
A strong positive association was also found between EDQLS scores and stage of change (F = 15.1 p <.001). Pearson's
correlations between the EDQLS and criterion instrument scores were .71 for the SF-12 mental subscale, .61 for the
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QoLI and .78 for the 16D, supporting construct validity. Exploratory principal components and item response theory
analyses identified only a few poor fitting items.
Conclusion: The EDQLS has promising psychometric characteristics and may be useful for evaluating ED treatment
effectiveness.
Background
In an increasingly appearance obsessed society, eating dis-
orders (EDs) including anorexia nervosa (AN), bulimia
nervosa (BN), and eating disorders not otherwise speci-
fied (EDNOS including binge eating disorders) represent
a serious health threat to children, youth, and adults of
both sexes [1]. Recent population-based data provide
stronger evidence of increased prevalence of EDs in recent
birth cohorts, and confirm that only a minority of cases
have received treatment [1]. Increased prevalence of
unhealthy dieting behaviors that elevate risk for the devel-
opment of EDs is also disturbing. Recently published
studies document disordered eating attitudes and behav-
iors in 27–29% of girls aged 10–18 years and increases in
concern with weight over time among boys and girls aged
9–14 [2-4]. These trends imply that EDs will continue to
be a significant health concern for the foreseeable future.
If not treated early and effectively, EDs can become
chronic, and place enormous burden on the patient and
his/her family [5]. Demand for treatment services is grow-
ing along with an urgency to ground new treatments in
evidence [6,7]. Treatment outcome measurement in EDs
has traditionally focused on changing behavior and symp-
toms (e.g. reducing purging or achieving healthy body
weight) rather than on broader areas such as role func-
tioning or quality of life (QoL). Despite calls for a broader
approach to outcomes [8-10], a recent review article on
treatment outcome assessment listed no measures other
than those of symptoms and behaviors and did not use
the term 'quality of life' [11].
The impact of EDs on broader life functioning is well doc-
umented [12], and measures of treatment success that
reflect these broader areas are in keeping with the trend in
contemporary health services toward measuring out-
comes, such as QoL, that are important to patients [13]. In
practice, the use of broader outcome measures in EDs has
been limited by a lack of availability of specific QoL meas-
ures that are suitable for a broad age range (young adoles-
cents through mid-life adults).
Generic measures such as the NHP, SF-36/12, and the
WHOQoL-Bref have been used in ED samples in research
studies and have been found to discriminate between nor-
mal and ED populations in measured functioning or QoL
[12], but they have some drawbacks. Some domains and
items may be insensitive for some ED diagnoses [14], they
are not developmentally oriented in content or language,
and responsiveness may be inadequate for evaluative pur-
poses [15,16]. Adult QoL measures are usually not appro-
priate for use in children and adolescents [17]. Wording
and interpretation problems with the SF-36 have been
found for some patient groups including EDs [14,18,19].
Many authors have emphasized the importance of meas-
uring QoL in a way that is meaningful to patients in health
services including ED services [13,20-24]. Meaningful
measurement requires more than trivial involvement of
patients in instrument development. Such involvement is
infrequent in measure development, especially in younger
ages. In a recent systematic review, Cremeens et al. found
that a minority of instruments specifically developed for
children included them in development, typically relying
instead on expert panels to generate items [25].
There has been increasing consensus in the ED field that a
specific, relevant and responsive QoL measure is needed
to evaluate patient outcomes, improve ED programs, and
test new treatments [12,19,26-29]. Three new disease-spe-
cific instruments for EDs were reported in 2006 [27-29].
Two of these focus predominantly on symptoms and
behaviors [28,29]; one was tested on inpatients only [29];
one addresses four broader domains but has no ED symp-
tom and behavior items [27], and none reported consid-
ering suitability for adolescents in design. This research
has rectified a total lack of knowledge about disease-spe-
cific QoL measurement for EDs in a short time, yet some
challenges remain. de la Rie et al. recently studied patient
preferences for QoL domains using a generic individual-
ized QoL tool and these preferences are not in alignment
with the domains of existing measures [23]. Neither does
any of the existing measures allow for assessment of indi-
vidual QoL, which is essential to client centered care
[20,23].
An additional concern which has been raised but not yet
addressed is the influence of ego-syntonicity on self-
reports of QoL [12,14,26]. Ego-syntonicity occurs when
the illness behaviors are initially consonant with the indi-
vidual's desires and goals (e.g. he/she may feel in control
and proud of achieving a desire weight loss and may have
received compliments on that) [30]. He/she will deny or
will be unable to comprehend the negative effects of the
behavior. In the context of QoL measurement, this lack of
insight could manifest as inflated QoL reporting (typicallyHealth and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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early in treatment) despite clear objective evidence of
adverse effects on health and functioning.
This article reports on the development and validation of
a condition-specific QoL instrument (the Eating Disorders
Quality of Life Scale (EDQLS)), designed to minimize
response bias attributable to ego-syntonicity in EDs, to
allow for both standard and individualized QoL assess-
ment, to be sensitive to change with treatment, and to be
developmentally appropriate for adolescents and young
adults, while also being suitable for adults with EDs. In
this article, we report on findings arising from the analysis
of baseline data from a longitudinal multi-site develop-
ment and validation study.
Methods
The general approach
The development of the EDQLS was grounded in the
World Health Organization's definition of QoL, which
conceptualizes QoL as subjective, multi-dimensional,
having positive and negative aspects and covering at a
minimum physical, psychological and social dimensions.
It is "individuals' perception of their position in life in the con-
text of the culture and values system in which they live and in
relation to their goals, expectations, standards and concerns"
[31]. This definition is congruent with draft industry
guidelines for "health-related quality of life", which, in
the context of medical treatment, is the patient's percep-
tion of the impact of the illness and its treatment on, at a
minimum, these same domains. [32]
The EDQLS was developed with an evaluative  purpose,
that is to measure change over time within individuals,
versus for example, a discriminative measure – which is pri-
marily intended to show differences between patient
groups or patients and healthy individuals [33,34]. Thus
the emphasis in design was on responsiveness, for both
assessment of patients' treatment progress and the out-
comes of new treatments such as in clinical trials. EDQLS
content was selected to measure the broader aspects of life
that were confirmed to be important to patients including
those which are specifically affected by EDs and their
treatment (i.e. health-related QoL). However, too much
overlap in content with existing instruments that measure
ED symptoms and behaviors alone was avoided.
EDQLS development was guided by published standards
[22,24,34,35], with emphasis on six recommendations: to
define QoL at the outset, to specify the intended purpose,
to use multiple sources for item generation (especially
patients), to reduce items according to respondent impor-
tance ratings and meaningfulness/sensibility rather than
relying solely on factor analytic processes, to use system-
atic approaches to pre-testing, and to incorporate longitu-
dinal validation for evaluative instruments.
Three disorder-related design issues were addressed. First,
the potential for underreporting of sensitive life issues
related to QoL in EDs (e.g. substance abuse, sexual abuse)
in in-person interviews at the domain/item development
stage was considered. To address this issue a set of inter-
net-based narratives written and posted anonymously by
individuals with current or past EDs was included. Sec-
ond, concerns about potential reporting bias due to the
egosyntonic nature of EDs (in particular AN) were
attended. Third, a tool suitable for the age range that
encompasses most presenting patients was desired, to
reduce the necessity for multiple instruments. Two meas-
urement-related design issues were also addressed. First,
standardization for comparability was valued but not
completely at the expense of allowance for assessment of
individual QoL preferences. Second, the need to systemat-
ically select items that were amenable to change (in keep-
ing with the evaluative purpose) was emphasized in
design.
Development of the EDQLS – domain and item generation
A multi-source and multi-stage process (Figure 1) with
participation of adolescents and young adults with EDs,
their families and treatment providers was used to
develop and finalize the draft instrument. Participants in
the development stage were patients with diagnosed eat-
ing disorders (AN, BN and EDNOS) from the Calgary Eat-
ing Disorders Program (CEDP), aged 14 and over, and
their family members. It was recognized that special, in-
depth methods (e.g. cognitive interviewing) would be
needed to confirm suitability of the EDQLS for those
under age 14, and numbers of younger eligible partici-
pants were very small, so validation in this group was set-
aside for a separate study. The CEDP provides day and
outpatient treatment and serves a regional population of
nearly 1 million. Illness severity is quite high due to high
service demand and limited availability. Health profes-
sionals with ED experience from five other service sites
across Canada were also involved in development.
Four sources of material were tapped for domain and item
generation (the peer-reviewed literature, treatment pro-
vider interviews, patient/client interviews and internet-
based first person narratives).
First, a systematic literature search for abstracts on the
topic of QoL in EDs was conducted, yielding 228
abstracts. Five investigative team members (both research-
ers and clinicians) then independently rated each abstract
on a standard relevancy statement "the experience or phe-
nomenon of eating disorders and its impact broadly on the per-
son's life from the patient's perspective is the central focus of the
abstract" using a four-point scale. Articles that were rated
as relevant by at least three raters and had scores above an
a priori cut-off were retained for content analysis (N = 39).Health and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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Second, 10 health professionals with clinical experience
in EDs from five sites and multiple disciplines (nursing,
dietetics, pediatrics, psychology, psychiatry, social work
and family medicine) were interviewed.
The EDQLS Development Process Figure 1
The EDQLS Development Process. * included nursing, dietetics, pediatrics, psychology, psychiatry, social work and family 
medicine; all with EDs clinical experience. ** Final domains: cognitive functioning, education/vocation, family and close relation-
ships, relationships with others, future/outlook, appearance, leisure, psychological health, emotional health, values and beliefs, 
physical health and eating issues.
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Third, in-depth semi-structured interviews were held with
12 patients ranging in age from 16 to 29 (58% under 18).
The number of participants involved in this phase was
constrained by the number of eligible patients in the
CEDP, the challenges of recruitment in this patient popu-
lation and the recognition of the need for participants in
subsequent phases of testing. The questions used to elicit
thoughts on ED and QoL in patient and provider inter-
views were similar to the operational definitions for
extracting concepts about ED and QoL from articles and
narratives. These questions targeted phrases or ideas that
addressed the "areas of life most affected by EDs" and
those "most impacted by recovery". Approximately 2000
units of text were extracted from the four sources using
content analysis [36]. After eliminating redundancies, five
team members independently grouped the concepts using
a card-sort approach, and consensus discussion resulted
in 12 QoL domains. Next, 233 item stems were derived
from the text units for each domain, retaining the patient's
phrasing where possible.
Finally, 31 first person narratives posted by individuals
with EDs on the internet and reporting on impact of these
illnesses on QoL were systematically sampled and simi-
larly analyzed. The first person narratives were used to
confirm themes arising from patient interviews, to iden-
tify sensitive issues that might be under-reported in face-
to-face interviews, and to improve generalizability of
extracted themes beyond the local site (see Adair et al.
2006 for more detail on this component) [37]. The addi-
tion of this component increased the material represent-
ing the patient perspective to 43 individuals.
Development of the EDQLS – item reduction
Item generation was followed by four stages of pre-testing
to reduce the item pool. In the first step, the 12 domains
of QoL as well as a selection of 59 items with specific con-
cerns were tested in two in-depth focus groups with five
patients (aged 15–22). For example, participants were
probed about whether the item captured their language
and the language of their peers and whether they felt it
was relevant to their QoL. The domains were endorsed as
presented and suggestions for item additions and revi-
sions were made. Next the item pool was reduced to 130
through a process of investigative team ratings on four
principles, followed by team consensus decisions. The
principles were:
￿ Directionality/Responsiveness: the item is expected to be
sensitive to change in a linear direction over time with
treatment (at this stage a specific assessment of the risk of
response bias for each item attributable to egosyntonicity
was also made)
￿  Universality:  the item captures behaviors/feelings of
individuals across ED diagnostic groups and a broad age
range with particular attention to inclusion of younger
ages
￿  Wording/Ambiguity:  the item is clearly worded and
understood and is unlikely to evoke a variety of interpre-
tations
￿ General Likeability: the item resonated with focus group
participants and is felt to be appropriate for the target
population
At this stage the items were also mapped against those in
the Beck Depression Inventory (BDI-II) [38] and the Eat-
ing Disorders Inventory (EDI-2) [39] and the degree of
conceptual overlap was rated by the investigative team to
be reasonably minimal (12 and 20% similar items respec-
tively). Next the 130 items were pre-tested with 17
patients (aged 14–40), 10 family members and 18 health
professionals. At this stage each item was rated as "good"
or "not good" according to its relevance for QoL and its
ability to show change with treatment. Respondents were
then asked to identify the "best three" items in each
domain, and to provide general comments about wording
(clarity, comprehension, ambiguity). Responses were col-
lected on a self-completed pre-tested form with research
assistant support as needed. A straightforward arithmetic
algorithm was used to identify the highest ranked items
and items were edited according to specific suggestions.
Ratings were consistent across respondent groups, but
where they diverged decisions to retain or eliminate items
followed the preference of the patients. After consensus
discussion, the investigative team retained the three high-
est rated items overall in each domain.
The final domains are listed at the bottom of Figure 1. The
six highest rated items in the eating issues domain were
retained to ensure specificity of the instrument to EDs,
resulting in a final set of 39 items across 12 QoL domains.
At the pilot stage we included one additional item with
nearly identical wording and meaning to another as a spe-
cific test of internal consistency. Final formatting of the
EDQLS included response scaling with a 5-point scale
with anchors "strongly disagree", "disagree", "neither
agree or disagree", "agree", and "strongly agree". Options
for response scale anchor terms had also been tested with
patients and there was a strong preference expressed for
the endorsement type anchors (i.e. "strongly disagree"
through "strongly agree") over frequency type response
anchors (e.g. always, sometimes, never). Participants
reported great difficulty with recall on proposed frequency
anchors and commented that they were "just guessing".
Items were also subjected to a readability check (Flesch-
Kincaid grades 5–7) and were balanced for polarity (neg-Health and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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ative vs. positive wording). Inclusion of both item types
was intended to minimize the effects of response sets. This
necessitates a reverse scoring procedure before analysis.
Example items from the final 40-item EDQLS are "I have a
lot of rules about food" (eating issues domain) and "I feel
connected to others" (relationships with others domain). A
single item global QoL rating (on a 10 point rating scale)
was added for overall construct validity assessment [24].
To allow for a more individualized assessment a separate
section of the instrument was designed which lists the 12
QoL domains and permits respondents to rate the impor-
tance of each as well as up to two additional self-nomi-
nated domains on a five-point importance scale. These
importance ratings are not used to weight the total
domain scores derived from the core 40 items as per cur-
rent recommendations [40] but they provide an opportu-
nity for the patient and clinician to consider and address
unique QoL issues and goals as an adjunct to the standard
scores.
Pilot and multi-site samples
Females and males over age 14 with a clinically confirmed
ED diagnosis (AN, BN or EDNOS) were eligible for both
the pilot and multi-site field test. Pilot participants came
from the CHR EDP and no males participated. The only
information collected other than the EDQLS in the pilot
was age, sex, time in treatment, and completion time. For
the multi-site study, 12 programs (two in Nova Scotia,
three in Manitoba, five in British Columbia, and two in
Alberta) providing any of inpatient, outpatient, day treat-
ment and/or consultation to adolescent or adult patients
participated.
Validation measures and other variables
Validation instruments included the Short-Form-12 (SF-
12) [41], the Quality of Life Inventory (QoLI) [42] and the
16D [43]. The SF-12 is a brief version of the SF-36, an
extensively tested and validated health status instrument
used in many patient populations to measure health-
related functioning and frequently used as an indicator of
QoL. It has 12 items that address activities such as playing
golf and climbing stairs, plus limitations in performing
physical tasks, and in working or socializing due to phys-
ical and emotional problems or pain and provides sum-
mary scores for mental and physical functioning/status
[41]. The QoLI is a generic QoL life instrument with 32
items addressing 16 areas of life (health, self-esteem, goals
and values, money, work, play, learning, creativity, help-
ing, love, friends, children, relatives, home, neighbor-
hood and community) and includes importance and
satisfaction ratings for each. It has been validated in sev-
eral clinical and non-clinical populations with internal
consistency values ranging from .77 to .89 [42]. The 16D
is a generic QoL measure designed specifically for youth
aged 12 to 15. It has a single item in each of 16 domains
(mobility, vision, hearing, breathing, sleeping, eating,
elimination, speech, mental function, discomfort and
symptoms, school and hobbies, friends, physical appear-
ance, depression, distress and vitality) with good test-
retest reliability and known group validity [43]. The 16D
was chosen to assess the appropriateness of the EDQLS for
adolescents.
Baseline severity of illness, psychiatric comorbidity and
stage of readiness to change ED behaviors were hypothe-
sized as key predictors of QoL and potential confounders
of other group comparisons. Standardized and validated
instruments – the Brief Symptom Inventory (BSI) [44],
EDI-2 [39] and the Motivational Stages of Change for
Adolescents Recovering from an Eating Disorder
(MSCARED) were used to measure these variables respec-
tively [45]. The MSCARED is a self-report measure to
assess stage of readiness to "take action" against an ED
behavior. The respondent endorses one of six statements,
each representing a stage of change. In an ED sample,
good test re-test reliability (r = .92), concurrent validity
with clinician ratings (r = .79) and predictive validity with
treatment outcomes [45] were found for the MSCARED.
The battery of measures was reviewed by clinical collabo-
rators at the sites for appropriateness for the target popu-
lation. The content of standard instruments could not be
changed, but this step was felt to be important for identi-
fying any issues with items to inform interpretation of
results. The instrument battery was also pre-tested with
eight adolescents/young adults aged 13 to 31 for burden,
comprehension, and completion time.
Other variables of interest: age, sex and rating of state
wellness (current day) were collected via self-report dur-
ing baseline instrument administration. The remaining
variables (site, treatment status at enrolment (inpatient or
outpatient)), psychiatric and medical comorbidity, prior
treatment, age at first symptoms, illness duration, current
program treatment duration and most recent BMI were
collected from the health record using a standard, pre-
tested abstraction form.
Data collection and management
Participants were recruited through presentations by the
research assistant in group therapy sessions, and by indi-
vidual clinician referrals. The baseline battery of instru-
ments was self-completed in hard copy on-site with
assistance as needed, then taken back to the central study
office. There, data were entered to an SPSS database and
error rates were measured on a 10% random sample and
found to be below 1%. Missing data was minimal, and
handled using standard decision-rules (e.g. inserting sub-
scale means) and dual-rater agreement on items requiring
judgment (such as potentially ambiguous respondent cor-
rections).Health and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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Analysis
Cronbach's alpha was computed for internal consistency
reliability of the total scale and each developed domain.
Next, corrected item to total correlations and the impact
of item deletion on Cronbach's alpha were evaluated.
There is a lack of consensus on whether stability over time
(measured by test re-test reliability) is a suitable psycho-
metric characteristic of an evaluative instrument. By
design the scores of an evaluative instrument should
change over time in response to treatment, making
responsiveness the more important characteristic [35]. For
this reason we deferred examination of test re-test reliabil-
ity to a subsequent study. Construct/criterion validity was
examined in bivariate analysis of EDQLS total scores
according to demographic and clinical characteristics
using ANOVA and Tukey's HSD post-hoc analysis. A pri-
ori hypotheses for convergent and divergent correlations
between EDQLS items and total score and criterion instru-
ment items/total scores were tested using Spearman corre-
lations and Pearson's correlations. This analysis focused
on items and total scores because of the preliminary
nature of the domains. Principal components analysis
(PCA) and item response theory (IRT) analyses were used
for initial, exploratory review of instrument and item
properties after confirmation of data suitability [46]. Next
an initial impression of the number of underlying factors
was made using Kaiser's criterion (eigenvalues >= 1), Scree
plots and Horn's parallel analysis using Monte Carlo PCA
[47], followed by varimax oblique rotations on item clus-
ters. Muraki and Samejima graded response models (in
Parscale software) were used for exploratory IRT analysis
[48].
Ethics
All stages of the study were reviewed and approved by the
Conjoint Health Research Ethics Board at the University
of Calgary. The protocol for the multi-site validation study
was approved by the respective committees for each juris-
diction.
Table 1: Participant demographic and clinical characteristics (baseline)
Characteristic N Mean (SD) Range
Age (years) 170 25.3 (10) 14–60
Age at First Symptoms (years) 123 15.3 (4.7) 8–40
Duration of Illness (years) 122 9.7 (9.1) 0–45
Time in Treatment (months) 129 12.5 (15.8) 0–85
Body Mass Index (weight in kg/height m2) 121 20.6 (4.5) 14–39
N Frequency (%)
Sex (% female) 171 165 (96.5)
Treatment Status at Enrolment (% outpatient) 171 160 (93.6)
Time in Treatment (current service) 129 35 (27.1)
<3 months 52 (40.3)
3–12 months 42 (32.6)
12+ months 86 (66.2)
Previous Treatment (%) 130 48 (28.1)
Primary Diagnosis 169
AN (restricting type) 24 (14.0)
AN (binge-purge type) 55 (32.2)
BN 42 (24.6)
EDNOS
Psychiatric comorbidity (% >1 DSM-IV diagnosis) 130 89 (68.5)
Medical comorbidity (% any) 130 45 (34.8)
Body Mass Index Category 121
Underweight 42 (34.7)
Normal 65 (53.7)
Overweight 10 (8.3)
Obese 4 (3.3)
Stage of Change (MSCARED category) 130
Pre-contemplation 1 (.8)
Contemplation 10 (7.7)
Preparation 20 (15.4)
Action 65 (50.0)
Maintenance 32 (24.6)
Recovery 2 (1.5)Health and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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Results
The pilot sample comprised 41 females with EDs from the
Calgary program aged 15–44 (mean 24.4, SD 8). Seven-
teen (43%) had been in treatment for less than three
months; 11 (28%) for 3–8 months, and 12 (30%) for
more than eight months. Internal consistency of the
EDQLS was high in the pilot (Cronbach's alpha = .95).
Exploratory results of the pilot sample were so similar to
the baseline data for the multi-site study that the samples
were pooled for the item analysis reported herein (N =
171). Subgroup and comparative instrument findings are
reported for the 130 participants from the multi-site
study.
Participant demographic and clinical characteristics are
shown in Table 1. Only six males participated due to small
Table 2: Relationships between EDQLS Scores, Demographic and Clinical Variables
Variable N EDQLS Total Scale Score* Mean (SD) Test Statistic and significance level†
Age Group
< 18 50 115.7 (30.5) F = 1.31 ; .273
19–24 55 107.9 (27.8)
25–29 21 102.8 (30.3)
>30 44 109.5 (21.4)
Primary Diagnosis
AN (restricting type) 48 108.6 (28.3) F = .785 ; .504
AN (binge-purge type) 24 105.2 (28.0)
BN 55 109.6 (24.0)
EDNOS 42 115.2 (31.1)
Psychiatric Comorbidity F = 9.10 ; .003
Yes 88 103.3 (22.5)
No 42 117.9 (31.3)
Medical Comorbidity
Yes 45 102.9 (22.0) F = 2.63 ;.107
No 85 110.8 (28.2)
BMI Category
<18 42 110.4 (30.3) F = 1.22 ; .304
18.5–24.9 65 109.0 (25.9)
25–29.9 10 97.3 (18.9)
30+ 4 90.7 (15.6)
Age First Symptoms
<12 years 32 104.0 (22.3) F = 1.75 ; .161
13–15 49 114.2 (25.7)
16–18 20 112.7 (35.7)
18 or over 22 101.6 (22.3)
Stage of Change**
Pre-contemplation/Contemplation 11 81.9 (15.0) F = 15.1 ; .000
Preparation 20 90.8 (12.3)
Action 65 108.7 (22.3)
Maintenance/Recovery 34 125.4 (29.6)
Time in Treatment
<3 months 35 110.3 (29.0) F = 4.65 ; .011
3–12 months 52 100.0 (23.6)
12 months or more 42 116.0 (25.4)
Psychiatric Symptom Severity^
Low 43 135.3 (22.6) F = 86.9 ; .000
Med 45 101.3 (11.2)
High 42 87.4 (16.4)
ED Symptom Severity#
Low 43 136.1 (21.2) F = 95.3 ; .000
Med 42 100.5 (12.5)
High 45 88.1 (26.4)
* EDQLS – possible scores range from 0 to 200 with higher scores indicating higher QoL.
** As measured on the MSCARED
^ BSI – Global Severity Index
# EDI-2 – Total score across all subscales
† using Analysis of Variance. Differences that are statistically significant at least at the .01 level are in bold text.Health and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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proportions of males in all participating programs. Nearly
30% of the sample was under 18 years of age and three
quarters was under 29 years.
Item distributions, overall score and reliability
Mean completion time was five minutes (range 2 to 11).
All items showed good dispersion (minimal ceiling or
floor effects) and all items had responses in all categories.
The total EDQLS raw score is derived by summing the
item ratings. The mean total score was 110 (SD 27.6;
range 56 to 187) out of a total possible score of 200 (rep-
resenting the highest QoL). Subscale scores are also sums
of item ratings for the 12 theoretically developed
domains. The scale was found to be highly internally con-
sistent (Cronbach's alpha .96). This value was virtually
unchanged for any item deletion. Item to total correla-
tions ranged from .28–.76 with only three items having
item to total correlations below .40 and no items com-
pletely redundant. Cronbach's alphas between defined
domains and the overall score were as follows: cognitive
functioning (.73); education/vocation (.76); family and
close relationships (.36), relationships with others (.69),
future/outlook (.64), appearance (.76), leisure (.50), psy-
chological health (.71), emotional health (.68), values
and beliefs (.72), physical health (.61) and eating issues
(.79). Two of the poorest fitting items were from the fam-
ily and close relationships domain and one from the lei-
sure domain.
Validity
Patterns of EDQLS scores by other variables are shown in
Table 2. EDQLS score distributions varied somewhat by
program and province but these differences were not sta-
tistically significant (F 1.34, p = .20 and F = .802, p = .49
respectively). Scores were lower for inpatient vs. outpa-
tient and males vs. females but these differences were not
tested for statistical significance because of very small
numbers of males and inpatients. Patterns of reported
QoL across all variables were consistent with predicted
directions. Differences were not significant by age, diag-
nosis, medical comorbidity, BMI or age at first symptoms.
Those in treatment longer reported statistically higher
QoL scores except for the initial group (in treatment less
than 3 months) (Figure 2). Those with psychiatric comor-
bidity (greater than one DSM IV diagnosis) had signifi-
cantly lower EDQLS scores, as did those with higher levels
of psychiatric symptom severity (on the BSI) and ED
symptom severity (on the EDI-2). The severity patterns
held across all nine subscales of the BSI and all 11 sub-
scales of the EDI-2 at the p < .001 level. A strong linear and
statistically significant association was found with
reported stage of change – with a 43 point spread in
EDQLS scores between those in pre-contemplation or
contemplation and those in recovery or maintenance (Fig-
ure 3).
Findings for comparisons with criterion QoL instrument
items and scale scores (including convergent and diver-
gent validity) are shown in Table 3. The magnitudes of
correlations were moderate to strong for nearly all com-
parisons predicted to be correlated. The mean correlations
across items predicted to be correlated were rho= .42, .37
and .55 for the SF-12, QoLI and 16D whereas the mean
correlation for items predicted to be poorly correlated was
rho= .19). Overall the EDQLS total score was highly cor-
related with the 16D weighted total score (r =.78, p <
.001), the QoLI weighted total score (r = .61, p < .001) and
the mental subscale of the SF-12 (r = .71, p < .001). A
lower correlation, as expected, was found between the
EDQLS total score and the SF-12 physical subscale (r =
.37, p < .001). Construct validity was also supported by
highly significant positive correlations with the EDQLS
global quality of life item, the SF-12 health status item
and the current wellness question.
Despite a relatively small sample size for PCA and IRT
analyses the initial tests of sample suitability were reassur-
ing. Bartlett's test of sphericity was highly significant (p <
.001) and the Kaiser-Meyer-Olkin value was .93. Most of
the values in the item correlation matrix fell between .3
EDQLS Total Scale Scores by Time in Current Treatment  Program Figure 2
EDQLS Total Scale Scores by Time in Current Treatment 
Program.
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and .6. PCA indicated up to eight factors accounting for
64.4% of the variance using the eigenvalue >1.00 criterion
with the first two components accounting for 44.1%. The
scree plot and parallel analysis suggested two to three fac-
tors. Varimax oblique rotation provided an initial sense of
possible item groupings with one cluster indicative of eat-
ing disorders behaviors and effects, and others suggestive
of future outlook, work/leisure and psycho-social-emo-
tional issues. However, thematic interpretation was
deferred for confirmatory analysis in larger samples.
Despite the relatively small sample, both IRT models con-
verged satisfactorily. The Samejima model, which does
not assume equal intervals between response options
across items fit the data significantly better than the
Muraki model, which does (χ2= 333, p < .05). Item char-
acteristic and item response curves indicated large con-
cerns with only one item in both models and moderate
concerns with 2–7 items depending on the model. The
two items of greatest concern are those identified earlier in
the classical analysis and point to a need for item replace-
ment in the family and close relationships domain, if this
pattern holds in the longitudinal analysis.
Discussion
A condition-specific QoL scale for EDs has been devel-
oped, for which initial results are promising. Face and
content validity are supported by a multi-source, patient-
centered development process. Results suggest that an
overall construct of QoL is being tapped by the EDQLS,
with a primary domain of eating disorders issues, and
some additional item clusters representing broader life
issues. Only a few items display poor fit characteristics.
Validity is supported by moderate to strong correlations
for most hypothesized relationships with well constructed
and validated generic QoL instruments. Appropriateness
for adolescents was supported by the pattern of correla-
tions with the 16D and correlations in total scores with
the SF-12 and QoLI offer reassurance that the adolescent
perspective was not taken at the expense of appropriate-
ness for adults. A much stronger correlation between the
EDQLS total score and the SF-12 mental component vs.
the SF-12 physical component is consistent with previous
studies [14,19,49,50]. It underscores the strong psychoso-
cial pathology of EDs but also suggests that the physical
functioning items of the SF-36/12 may not be optimal for
capturing the impact of EDs on physical health, and is
congruent with concerns about suitability of some of the
SF-12 items for the ED population [14,19]. Several of our
participants spontaneously questioned the suitability of
the SF-12 in response to its generic nature (e.g. "some of my
experiences of an eating disorder weren't covered much") and
some noted that examples provided for some SF-12 items
(e.g. bowling or playing golf) were difficult to relate to.
Patterns of EDQLS scores were consistent with expecta-
tions although power was not adequate for some analyses.
No statistically significant differences were found by age,
age at first symptoms, medical comorbidity, BMI or diag-
nosis. In a community sample, Hay et al. found no asso-
ciation between age of onset and QoL in BN although
older individuals reported lower QoL [51]. Lower QoL
has also been reported for older individuals in other psy-
chiatric disorders [26] but in the QoL literature in ED age
is often used as an adjusting variable – rather than being
reported separately. Differences in QoL according to BMI
have been examined for diagnostic subpopulations only
(e.g. Hay 2003) [51] and typically show lower QoL at low
and high BMI levels. Our results for BMI are consistent
with that pattern, but were not statistically significant.
As expected, those with comorbid psychiatric diagnoses
and higher levels of psychiatric and ED symptom severity
reported significantly lower QoL as measured by the
EDQLS, a finding that is firmly established in the QoL in
ED literature [9,12,19,27-29]. It was also encouraging
that, with the exception of the most recent admission
group, participants who were in treatment longer reported
significantly higher EDQLS scores. This finding suggests
that treatment is associated with improved QoL and that
the EDQLS may be responsive to detecting changes that
occur over time. In this cross-sectional analysis, con-
founding by age and severity would likely dampen this
EDQLS Total Scale Scores by Stage of Change Reported at  Baseline Figure 3
EDQLS Total Scale Scores by Stage of Change Reported at 
Baseline.
Stage of Change
200.00
175.00
150.00
125.00
100.00
75.00
Precontemplation
+
Contemplation
Preparation Action Maintenance
 +
RecoveryHealth and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
Page 11 of 14
(page number not for citation purposes)
Table 3: EDQLS Total Score and Item Correlations with Validation Instruments for 130 Multi-site Participants at Baseline
Convergent Validity EDQLS Item Criterion Item – SF12 Spearman's rho* p
3 I have an open honest relationship with someone outside my family 12 Interference with social activities .22 .01
10 I feel connected to others 12 Interference with social activities .40 .000
16 I have fights with my family members about food and eating * 12 Interference with social activities .33 .000
19 I turn down opportunities to go out with friends * 12 Interference with social activities .62 .000
22 People don't understand me * 12 Interference with social activities .37 .000
28 I have to be in a relationship to feel good about myself * 12 Interference with social activities .01 NS
6 I hardly ever worry 9 How much ..time...felt calm/peaceful -.55 .000
21 I feel hopeful about the future 11 How much ..time....felt downhearted .51 .000
9 I have lots of energy 10 How much.. time ...did you have lots of energy -.75 .000
EDQLS Item Criterion Item – QoLI
11 I get satisfaction from my main activity 10 Satisfaction with work .55 .000
28 I have to be in a relationship to feel good about myself * 19 Importance of love -.28 .001
28 I have to be in a relationship to feel good about myself * 20 Satisfaction with love .06 NS
3 I have an open honest relationship with someone outside my family 19 Importance of love .07 NS
3 I have an open honest relationship with someone outside my family 20 Satisfaction with love .38 .000
19 I turn down opportunities to go out with friends * 22 Satisfaction with friends .30 .001
16 I have fights with my family members about food and eating * 26 Satisfaction with relatives .17 NS
21 I feel hopeful about the future 6 Satisfaction with goals and values .52 .000
27 I think about what I would like to do in my life 6 Satisfaction with goals and values .38 .000
1 I have fun with others 12 Satisfaction with play .33 .000
14 I enjoy relaxing in my free time 12 Satisfaction with play .28 .001
24 I enjoy participating in different activities, not just exercise 12 Satisfaction with play .27 .002
7 I show my true self to others 4 Satisfaction with self-esteem .39 .000
26 I am able to see good qualities in myself 4 Satisfaction with self-esteem .60 .000
30 I put myself down a lot * 4 Satisfaction with self-esteem .68 .000
5 My health is more important than my physical appearance 1 Importance of health .41 .000
31 I feel self-conscious about my body around others * 4 Satisfaction with self-esteem .60 .000
EDQLS Item Criterion Item – 16D
4 I have trouble concentrating 14 Mental function (thinking clearly and logically) -.52 .000
20 I can focus on things other than food 14 Mental function (thinking clearly and logically) -.39 .000
29 Thoughts about food and eating dominate my life * 14 Mental function (thinking clearly and logically) -.41 .000
39 The eating disorder has taken over my life * 11 School and hobbies -.59 .000
19 I turn down opportunities to go out with friends * 13 Making friends or being with them -.45 .000
13 I see positive things in my appearance 10 Weight, height and what I look like -.61 .000
9 I have lots of energy 1 Feeling healthy and energetic -.67 .000
25 I'm constantly trying to fix my body * 10 Weight, height and what I look like -.75 .000
38 I'm obsessed with my weight or my body shape * 10 Weight, height and what I look like -.75 .000
24 I enjoy participating in different activities, not just exercise 11 School and hobbies -.35 .000
31 I feel self-conscious about my body around others * 10 Weight, height and what I look like -.68 .000
21 I feel hopeful about the future 16 Feeling sad, melancholic or depressed -.49 .000
6 I hardly ever worry 4 Feeling anxious, stressed or nervous -.55 .000
32 My sleep is restful 6 Problems with sleeping -.51 .000
Criterion Item or Scale Score Pearson's r p
EDQLS Total Score SF-12 Health status item -.48 .000
Please rate how well you feel today. .56 .000
Please rate your overall quality of life in the last week (EDQLS global QoL 
item)
.73 .000
SF 12 Mental Subscale .71 .000
SF 12 Physical Subscale .37 .000
16D Weighted Total Score .78 .000
QoLI Weighted Total Score .61 .000
Divergent Validity EDQLS Total Score
16D 2 Vision -.08 NS
16D 3 Breathing -.32 .000
16D 5 Hearing -.21 NS
16D 9 Speech -.28 .001
16D 12 Walking -.04 NS
* refers to items that are reverse scored for analysis.Health and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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association since those in treatment longer would tend to
have greater severity of illness and would be older. Longi-
tudinal analysis will allow disentangling of these factors
and provide stronger evidence for responsiveness. A
highly statistically significant association was found
between EDQLS scores and sequential levels of reported
stage of change. This suggests that QoL improves with
readiness to change, and by implication, a treatment
approach which considers stages of change theory is con-
sistent with a recovery process that results in better QoL.
With respect to diagnosis – several studies have found no
differences among ED diagnostic groups on QoL as meas-
ured by the SF-36/12 [9,49] but Mond et al. did find that
the AN restricting subgroup reported significantly better
QoL than other patient groups after controlling for levels
of general psychological distress [26]. Doll (2005) had
similar findings but also noted that those with AN also
reported more depression, self-harming behavior and sui-
cidal ideation [14]. These authors' explanation for the
finding was that the SF-36 is insensitive in measurement
of the way that distress in AN impacts functioning. The
finding in the current study of no difference by diagnosis
was a desirable endpoint in that items were deliberately
and systematically selected to apply across diagnoses and
to minimize egosyntonic responding. The perspectives of
health professionals and families were also incorporated
and participants at later stages of recovery were asked how
they might have responded to specific items earlier in
treatment.
These efforts seemed to minimize this bias on a group
basis, but the phenomenon may still have been operating
in some respondents. A handful of scores above 180 on a
scale of 200 seemed to be unrealistically high for individ-
uals referred to tertiary health services as a result of signif-
icant symptom levels. These scores, informally, seemed to
be reported by individuals who were younger and had a
diagnosis of AN. One was an inpatient, several partici-
pants were underweight (as measured by their BMI), and
others were recent entries to treatment with shorter dura-
tions of illness. It may be that the ED had not yet fully
impacted the broader life of these individuals, but it is
also possible that these patients lacked insight into the
impact of their illness on their QoL as a result of egosyn-
tonicity. Further study of these initial observations is
needed. Until more is known about the reasons for this
phenomenon it may be prudent to use repeated measures
at several time points in treatment (vs. start and endpoint
measures) and some caution should be taken in interpret-
ing QoL scores in early treatment stages. Our data suggest
that after about three months of treatment score trajecto-
ries appear to be valid, and stronger evidence is forthcom-
ing from our longitudinal study. While a central principle
of QoL measurement is that it must be reported by the
patient him or herself, caution is recommended in using
scores based on self-reports that are in great divergence
with the observations of clinicians or family members to
make important decisions about treatment outcome.
Stage of change ratings may also be valuable adjunct
information.
Twelve domains have been endorsed by our respondents
as being important to their QoL; which is a large number
in comparison with the number of domains in the other
new disease-specific instruments which range from four to
eight [27-29]. However, using similar patient-centered
processes, de la Rie and colleagues identified 11 domains
of importance (sense of belonging, family/friends, self-
image, well-being, health, ED psychopathology, life-skills,
work/education, sense of purpose/meaning, financial/liv-
ing condition) most of which parallel the EDQLS
domains quite nicely. Twenty-seven respondents in this
study also nominated individually relevant domains, con-
firming the utility of including an individualized
approach, but most of these were specific instances of one
of the existing domains or relatively unique individual
values (music, religious faith, relationship with nature).
The financial domain identified by both Engel and de la
Rie [23,27] did not emerge in the current study – possibly
because of a combination of younger participants who are
not yet financially independent and the context of pub-
licly funded healthcare services in Canada.
General response to the EDQLS by participants in our
study was very positive. Some respondents commented
that it was refreshing and interesting to be completing a
scale that addressed their broader life interests and con-
cerns, not just ED symptoms and behaviors. One respond-
ent commented "As eating disorders are about more than
food/weight, I think that this type of study/questionnaire is a
more accurate representation of where a person is at in regards
to the effects of an ED". The contribution that adolescents
and young adults can make to instrument development
may be underestimated in QoL research. In this research,
young participants were insightful about their QoL, able
to capably articulate their ideas about the utility of items,
and able to offer excellent suggestions for revision. It was
humbling to find, that some of the most favored items of
the "expert" investigative team did not resonate with
patients. Completion of the EDQLS was reported to be
easy and took only about five minutes, which makes the
instrument acceptable and practical for administration in
clinical settings.
For the first time there is a range of choices for disease-spe-
cific QoL measurement in the ED population [27-29].
Instrument choice depends on purpose and population.
The EDQLS offers comprehensive measurement of
broader quality of life domains that have been confirmedHealth and Quality of Life Outcomes 2007, 5:23 http://www.hqlo.com/content/5/1/23
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to be important to patients as well as a symptom and
behavior domain. It has been validated against well estab-
lished generic QoL measures, predicts severity levels on
symptom measures, and is suitable for the age range of
most current ED patients.
Some limitations apply to this work. First, the develop-
ment work involved patients from only one program;
however the patient perspectives from the internet were
geographically broad, health professional perspectives
spanned multiple disciplines and five clinics, and the val-
idation study included patients across 12 programs in
four provinces. Domains were developed through consen-
sus processes to ensure broad coverage of QoL in this pop-
ulation, however, it is recognized that this number of
defined domains may never align fully with factor analy-
sis output. Sample size for baseline data analysis was not
sufficient for strong conclusions about differences for
some variables and for confirmatory factor and IRT analy-
ses. These will require larger samples. The EDQLS has
been tested in only six males so cannot be considered to
be sufficiently validated for boys and men. Suitability for
diverse ethnic groups is unknown.
French and Spanish translations have been produced but
are not yet validated. The EDQLS can not be recom-
mended for use in patients younger than 14 without fur-
ther validation although the reading level and initial
clinical impressions suggest that the suitable age bound-
ary may be lower. Egosyntonic responding was considered
in EDQLS development but may not be completely elim-
inated for some respondents. The extent to which socially
desirable responding may be influencing EDQLS scores
remains to be assessed. Proxy versions for health profes-
sionals and family members have been developed but not
yet tested. Clinically meaningful cut-points and differ-
ences have yet to be specified for the instrument and
responsiveness to be confirmed.
Conclusion
The EDQLS appears to be a promising condition-specific
QoL instrument that is appropriate for ED patients as
young as 14 and as old as 60. The findings that those in
treatment longer and in later stages of change report
higher QoL are encouraging and suggest that QoL out-
comes responsive to treatment may be measurable by the
EDQLS. Further research, including independent valida-
tion studies are recommended.
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